Coherus Oncology, Inc. (CHRS)
1.41
-0.05
(-3.42%)
USD |
NASDAQ |
Aug 28, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Coherus Oncology Shareholders Equity (Quarterly) : 60.84M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.84M |
| March 31, 2026 | 78.62M |
| December 31, 2025 | 61.01M |
| September 30, 2025 | 87.77M |
| June 30, 2025 | 119.83M |
| March 31, 2025 | -183.47M |
| December 31, 2024 | -131.99M |
| September 30, 2024 | -87.97M |
| June 30, 2024 | -84.11M |
| March 31, 2024 | -81.84M |
| December 31, 2023 | -193.42M |
| September 30, 2023 | -133.60M |
| June 30, 2023 | -174.76M |
| March 31, 2023 | -196.51M |
| December 31, 2022 | -137.42M |
| September 30, 2022 | -97.13M |
| June 30, 2022 | -22.63M |
| March 31, 2022 | 12.56M |
| December 31, 2021 | 97.73M |
| September 30, 2021 | 130.76M |
| June 30, 2021 | 156.22M |
| March 31, 2021 | 127.67M |
| December 31, 2020 | 280.97M |
| September 30, 2020 | 255.73M |
| June 30, 2020 | 213.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 157.28M |
| December 31, 2019 | 105.21M |
| September 30, 2019 | 56.02M |
| June 30, 2019 | -3.985M |
| March 31, 2019 | -38.52M |
| December 31, 2018 | -38.59M |
| September 30, 2018 | 12.39M |
| June 30, 2018 | 63.17M |
| March 31, 2018 | -1.794M |
| December 31, 2017 | 31.82M |
| September 30, 2017 | 56.20M |
| June 30, 2017 | 32.14M |
| March 31, 2017 | 78.18M |
| December 31, 2016 | 20.53M |
| September 30, 2016 | 32.87M |
| June 30, 2016 | -60.89M |
| March 31, 2016 | -66.01M |
| December 31, 2015 | -6.207M |
| September 30, 2015 | 40.57M |
| June 30, 2015 | 96.75M |
| March 31, 2015 | 38.15M |
| December 31, 2014 | 66.80M |
| September 30, 2014 | 9.334M |
| June 30, 2014 | 14.69M |
| March 31, 2014 | -60.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 101.07M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 191.18M |
| Total Liabilities (Quarterly) | 130.34M |
| Debt to Equity Ratio | 0.8905 |
| Current Ratio | 1.772 |
| Net Debt Paydown Yield | 22.69% |